Genito-Urinary
Genito-Urinary
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
18
Clinical Trials
Genito-Urinary
Phase III
Enrolling
nct/study# NCT06592924 / CCTG-PR26
A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Learn More
Genito-Urinary
Phase IV
Enrolling
nct/study# NCT06651632 / CSP0005
WATER IV Prostate Cancer: Aquablation versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer
Learn More
Genito-Urinary
Phase III
Enrolling
nct/study# NCT06952803 / D9727C00001
A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02)
Learn More
Genito-Urinary
N/A
Enrolling
nct/study# N/A / FOCAL
A Prospective Observational Protocol to Evaluate Clinical and Functional Outcomes After Focal Therapy in Patients with Prostate Cancer
Learn More
Genito-Urinary
Phase I/II
Enrolling
nct/study# NCT06818643 / MK-3120-002
A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants with Advanced Solid Tumors
Learn More
Genito-Urinary
Phase III
Enrolling
nct/study# NCT06925737 / MK2400-001
A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Treatment of Physicians Choice in participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.